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Abstract Propofol (2,6-diisopropylphenol)—an intravenous
anaesthetic—can be identified and quantified in expired air
directly. For the first time, a β-radiation ion mobility
spectrometer operated in the positive mode and coupled
to a multi-capillary column for rapid (seconds–minutes)
pre-separation (MCC/IMS) was used for the quantification
of Propofol in expired air. The comparison of the concen-
trations in exhaled air (300 pptV–5 ppbV) and in serum
(0.3–5 μg/mL) showed satisfying agreement affirmed by a
correlation coefficient of 0.73. Therefore, MCC/IMS is an
adequate method to determine Propofol concentrations in
exhaled air and may be applied for the prediction of venous
concentrations or for automatic anaesthesia control.
Keywords Propofol . 2,6-diisopropylphenol . Anaesthesia .
Serum . TIVA . Breath analysis . Ion mobility spectrometry .
GC/MS . GC/IMS
Introduction
The monitoring of volatile anaesthetics in end-tidal breath
is a standard procedure to improve safety of the patient and
to adjust anaesthetic depth. Presently, this is not easy to
perform for intravenous anaesthetics such as Propofol.
Complex and time consuming off-line analyses of blood
samples are required. Therefore, an on-line method for the
determination of the serum anaesthetics concentration is
desirable to improve safety and adjust anaesthetic depth or
the level of sedation in intensive care units (ICU).
The on-line measurement of Propofol in exhaled air
has already been demonstrated using different techniques
like proton transfer reaction mass spectrometry (PTR-
MS) [1, 2], thermal desorption gas chromatography [3]
and ion molecule reaction-mass spectrometry (IMR-MS)
[4]. Those investigations showed close relations of
Propofol concentrations in exhaled air and in blood [2–
4]. However, those instruments are expensive and in
general not commercially available as validated medical
instrumentation.
For the present study, an ion mobility spectrometer in
combination with a multi-capillary column (MCC/IMS)
was applied for the quantification of Propofol in exhaled air
for the first time as presented in [5] for the medical
community, in particular with regard to the possible routine
application. Here, the technical aspects will come to the
fore. The results were compared to serum concentrations of
Propofol determined by GC/MS. The MCC/IMS has
already been applied successfully for medical purpose [6–
8]. It is a suitable tool to analyse human breath as it
provides high sensitivity (down to pptV) and selectivity
combined with high-speed data acquisition (single spectra
0.1 s / complete breath analysis ∼5 min) and relatively low
technical expenditure.
Experimental
The bi-directional β-radiation MCC/IMS operated with
synthetic air under ambient pressure and temperature used
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for the study was custom designed at ISAS and has been
described in detail in literature as well as the software
used for data acquisition and evaluation [6–8]. For pre-
separation, a 20 cm un-polar multi-capillary chromatographic
column (OV-5, MULTICHROM, Novosibirsk, Russia) was
operated isothermal at 40 °C. Sampling was controlled by a
CO2 sensor (IRMA, Fa. PhaseIn, Danderyd, Sweden), which
was used to flush the sample loop (8 mL volume) only if
carbon dioxide exceeded 25 mmHg, thus sampling only end-
tidal breath. The volume of the sample loop was then
introduced directly into the MCC without any pre-treatment
of the sample.
Propofol (2,6-diisopropylphenol) is characterised by a
molecular mass of 178 u and a phenolic chemical structure.
Propofol and Thymol (used as internal standard) for
calibration were obtained from Sigma–Aldrich (Seelze,
Germany). A calibration gas generator (HovaCAL 3834SC
VOC, Inspire Analytical Systems GmbH, Frankfurt amMain,
Germany, see [9]) was used for calibration of MCC/IMS.
The generator provided Propofol concentrations (1, 3, 5, 7, 9
and 10 ppbv) in humid air (100% relative humidity at 37 °C).
The calibration results (correlation coefficient of 0.984,
n=24) are presented in Fig. 1. The Propofol concentration
could be determined by the MCC/IMS in breath with a mean
standard deviation of 2.5% and by GC/MS in serum with
12.2%.
Study population
Thirteen patients scheduled for an elective ear–nose–throat
surgery procedure (nine male, four female, all classified as
American Society of Anaesthetist physical status I or II, see
[10]) were involved in the study. In the mean, patients were
45 years of age and their body-mass-index (BMI) was 24.6
(Table 1). The study was approved by the ethics committee
of the University of Göttingen, Germany (protocol No. 01/
07/08). All patients gave written informed consent to
participate in the investigation.
Anaesthesia and sample acquisition
The patients received a standard total intravenous anaesthesia
(TIVA) with Propofol (Disoprivan 1%; Astra Zeneca, Wedel,
Germany) as hypnotic agent, Remifentanil for analgesia and
optional Rocuronium as muscle relaxant. Anaesthesia was
induced with intravenous application of 2.1 (±0.7) mg/kg
Propofol bolus and 30 μg/kg/h Remifentanil. After tracheal
intubation, the lung was ventilated with a standard anaesthesia
respirator (Cato, Dräger, Lübeck, Germany). Propofol (3.9
(±1.8) mg/kg/h) and Remifentanil (30 μg/kg/h) were applied
continuously to maintain anaesthesia adjusted to clinical
parameters. Sampling was performed as described above
and in Total Intravenous Anaesthesia in analogy to Schubert et
al. [11] measuring CO2 in breath with mainstream capnog-
raphy (IRMA, Fa. PhaseIn, Danderyd, Sweden). Breath
samples were drawn when the CO2 level exceeded 25 mmHg
and venous blood samples were obtained via a separate
venous access at the opposite site of the drug infusion
simultaneously. All samples were collected at steady state
conditions (achieved by administration of Propofol and
Remifentanil for 15 min). Depending on the duration of
surgery, one or two sample pairs of breath and serum were
taken per patient.
Determination of propofol concentrations by GC/MS
Breath samples have been adsorbed on Tenax tubes (1 L of
breath, controlled by the sampling control of the MCC/
IMS) and were thermally desorbed and analysed just as the
blood samples (injected in one bolus at 250 °C) using a
GC/MS with EI-ionisation (70 eV) by Agilent Technologies
6,890 N GC-system connected to an Agilent Technologies
5,973 mass selective detector (MSD; Gerstel, Mülheim,
Germany). The operating parameters were: SSL-injector
180 °C; column DB-5: 30 m; 0,25 mm ID; 0,25 μm FD;
1 mL/min He const.; T-program 40 °C/5 °C/min–100 °C/
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Fig. 1 Calibration of the MCC/IMS to gas-phase Propofol in humid air
Table 1 Demographics of the study population: Median (Min. Max.)
Sex (male/female) 9/4
Age [years] 45 (18 69)
Weight [kg] 76 (58 107)
Height [cm] 173 (160 183)
BMI 25 (19.6 38.8)
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20 °C/min–200 °C (5 min). Integrated signals from the
internal standard Thymol (m/z 135,150) and from Propofol
(m/z 163,178) were evaluated by AMDIS/NIST (Automat-
ed Mass Spectral Deconvolution and Identification System;
version 2.62, 2005; NIST version 2.0, 2005).
Simultaneously to breath sampling, venous blood was
from the arm that was not used for the infusion. All samples
were collected under steady-state conditions (Achieved by
administration of Propofol and Remifentanil for 15 min).
Depending on the duration of surgery, 1–2 samples were
obtained from each patient.
Results and discussion
In total 24 measurements were carried out during anaesthe-
sia of the study population. The Propofol signal in the
MCC/IMS spectra was identified via parallel Tenax
samples of breath and TD-GC/MS analysis earlier from a
different study population. The Propofol concentration in
exhaled air was determined by MCC/IMS and converted
into serum concentrations. The related serum Propofol
concentration was determined by GC/MS using the refer-
ence analyte for quantification. The comparison of both
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Fig. 2 Propofol concentrations in exhaled air determined by MCC/
IMS and converted into serum concentrations versus Propofol serum
concentrations determined by GC/MS. The solid line indicates a linaer
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Fig. 3 Deviation of the MCC/IMS concentration from the mean
concentration determined by both MCC/IMS and GC/MS. The dotted
lines indicate twice the standard deviation
Fig. 4 MCC/IMS chromatogram of Propofol with pre-separation
operated at 40 °C. The Propofol signal is indicated by the cross line
and the single spectra (bottom) and chromatogram (right) are
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Fig. 5 From calibration measurements, a decrease of the Propofol
retention time described by the formula tRðTÞ ¼ 118»T3:98 was
determined
Int. J. Ion Mobil. Spec. (2010) 13:37–40 39
coefficient of 0.73 was obtained. In contrast to Miekisch et
al. [12] but conformable to Grossherr et al. [3] a correlation
between venous serum and exhaled air Propofol concentra-
tion was observed.
To provide more general information about the reliability
of the serum Propofol concentration determined via breath
analysis, the MCC/IMS concentrations were compared to
the mean concentration as determined by both MCC/IMS
and GC/MS (see Fig. 3). The standard deviation of the
MCC/IMS compared to this normalised mean value was
with 12.3% in the same range as found when other
techniques are used [2–4].
For the present study, the pre-separation of the MCC/
IMS was operated at 40 °C. With this experimental setup,
the Propofol signal was detected with a mean retention time
of 474.5 s and a mean inverse reduced ion mobility 1/K0 of
0.6737 Vs/cm² (see Fig. 4). However, as the signal occurs
in general separated from others, the pre-separation tem-
perature may be increased to reduce retention time and
analysis time respectively.
Calibration measurements at different MCC temper-
atures showed, that retention time follows an almost
logarithmic decrease with increasing MCC temperature.
For Propofol, the correlation can be described by the
formula tRðTÞ ¼ 1:1»108»T3:98 (see Fig. 5). Exceeding
70 °C, retention time is already <1 min and at 100 °C only
10 s. The very isolation location of the Propofol signal in
the breath spectra would furthermore enable to use a 10 cm
MCC instead of 20 cm, which will halve the retention time.
Therefore, at 100 °C, the retention time of Propofol
concentration can be determined after about 5 s.
Conclusion
The correlation between exhaled air concentrations and
serum concentrations of Propofol was described for the first
time using a MCC/IMS. The system obtains a point of care
measurement with non-invasive sampling and reliable
prediction of venous Propofol concentrations without pre-
concentration. The on-line determination (5–10 s after sample
acquisition) of serum Propofol concentrations via breath
analysis with regard to safety factors is feasible for infusion
control at ICU and for Total Intravenous Anaesthesia
(TIVA).
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